Rui Suzuki
Hiroshima, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Glypican-1 is a novel immunohistochemical marker to differentiate poorly differentiated squamous cell carcinoma from solid predominant adenocarcinoma of the lung.
Journal: Translational lung cancer research
Published: March 15, 2021
SOX6 is a Novel Immunohistochemical Marker for Differential Diagnosis of Epithelioid Mesothelioma From Lung Adenocarcinoma.
Journal: The American journal of surgical pathology
Published: June 05, 2020
Inhibition of miR-18a-3p reduces proliferation of mesothelioma cells and sensitizes them to cisplatin.
Journal: Oncology letters
Published: October 11, 2019
miR-182 and miR-183 Promote Cell Proliferation and Invasion by Targeting FOXO1 in Mesothelioma.
Journal: Frontiers in oncology
Published: July 23, 2018
Mucin 21 is a novel, negative immunohistochemical marker for epithelioid mesothelioma for its differentiation from lung adenocarcinoma.
Journal: Histopathology
Published: July 09, 2018
Glypican-1 immunohistochemistry is a novel marker to differentiate epithelioid mesothelioma from lung adenocarcinoma.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: September 13, 2017
Utility of Survivin, BAP1, and Ki-67 immunohistochemistry in distinguishing epithelioid mesothelioma from reactive mesothelial hyperplasia.
Journal: Oncology letters
Published: June 30, 2017
PIM1 knockdown inhibits cell proliferation and invasion of mesothelioma cells.
Journal: International journal of oncology
Published: December 05, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026